FI
RARX

Fosun International’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Fosun International’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-108,073
Closed -$3.1M – 328
2019
Q2 		$3.1M Hold
108,073
– – 0.2% 75
2019
Q1 		$2.42M Hold
108,073
– – 0.15% 88
2018
Q4 		$1.97M Buy
+108,073
New +$1.7M 0.12% 86

Other funds holding RARX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Fosun International's RARX Position: Q3 2019 in Review

Fosun International sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q3 2019, closing a stake of 108,073 shares — an estimated $3.1M sold.

Fosun International first reported a position in RARX in Q4 2018 and held it in 3 quarters. The position peaked at $3.1M in Q2 2019. 119 funds tracked by Wall St. Rank hold RARX as of Q3 2019.

  • Fosun International reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 108,073 Ra Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $3.1M.
  • Fosun International first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 3 quarters.
  • Fosun International's Ra Pharmaceuticals, Inc. Common Stock position peaked at $3.1M in Q2 2019.
  • 119 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.